Page 58 - Strategies for non-invasive managementof high-grade cervical intraepithelial neoplasia - prognostic biomarkers and immunotherapy Margot Maria Koeneman
P. 58
Chapter 2
References
1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International journal of cancer Journal international du cancer. 2010;127(12):2893-917.
2. zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. Journal of the National Cancer Institute. 2000;92(9):690-8.
** this review illustrates that HPV is the cause of cervical cancer.
3. Jemal A, Simard EP, Dorell C, et al. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels. Journal of the National Cancer Institute. 2013;105(3):175-201.
4. Peto J, Gilham C, Deacon J, et al. Cervical HPV infection and neoplasia in a large population- based prospective study: the Manchester cohort. British journal of cancer. 2004;91(5):942-53.
5. McCredie MR, Sharples KJ, Paul C, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort
study. The lancet oncology. 2008;9(5):425-34.
6. Munk AC, Gudlaugsson E, Ovestad IT, et al. Interaction of epithelial biomarkers, local immune
response and condom use in cervical intraepithelial neoplasia 2-3 regression. Gynecologic
oncology. 2012;127(3):489-94.
7. Ovestad IT, Gudlaugsson E, Skaland I, et al. The impact of epithelial biomarkers, local immune
response and human papillomavirus genotype in the regression of cervical intraepithelial
neoplasia grades 2-3. Journal of clinical pathology. 2011;64(4):303-7.
8. Trimble CL, Piantadosi S, Gravitt P, et al. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clinical cancer research
: an official journal of the American Association for Cancer Research. 2005;11(13):4717-23.
9. Grimm C, Polterauer S, Natter C, et al. Treatment of cervical intraepithelial neoplasia with topical imiquimod: a randomized controlled trial. Obstetrics and gynecology. 2012;120(1):152-
9.
10. Barken SS, Rebolj M, Andersen ES, Lynge E. Frequency of cervical intraepithelial neoplasia
treatment in a well-screened population. International journal of cancer Journal
international du cancer. 2012;130(10):2438-44.
11. SpracklenCN,HarlandKK,StegmannBJ,SaftlasAF.Cervicalsurgeryforcervicalintraepithelial
neoplasia and prolonged time to conception of a live birth: a case-control study. BJOG : an
international journal of obstetrics and gynaecology. 2013;120(8):960-5.
12. Crane JM. Pregnancy outcome after loop electrosurgical excision procedure: a systematic
review. Obstetrics and gynecology. 2003;102(5 Pt 1):1058-62.
13. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric
outcomes after conservative treatment for intraepithelial or early invasive cervical lesions:
systematic review and meta-analysis. Lancet. 2006;367(9509):489-98.
14. Arbyn M, Kyrgiou M, Simoens C, et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis.
Bmj. 2008;337:a1284.
56
